Qbic Fund

Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company focuses on developing internal drug discovery programs centered on G-protein coupled receptors (GPCRs), which are critical targets for therapeutic intervention. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes active-state conformations of GPCRs, enabling researchers to access previously unreachable structural features. This innovation facilitates the discovery of novel agonists, addressing unmet medical needs and potentially leading to improved treatments in the medical field. The company aims to build a robust portfolio of drug discovery programs, leveraging its unique approach to enhance therapeutic options.

QustomDot is a company based in Ghent, Belgium, specializing in the development and manufacturing of on-chip grade and cadmium-free quantum dots. These tiny semiconductor nanoparticles are designed to transform ultraviolet or blue light into pure colors, enhancing the image quality of various display technologies. QustomDot's products are applicable in LED/LCD televisions, smartphones, smartwatches, virtual and augmented reality goggles, and LED lighting solutions. The company not only produces quantum dots but also assists customers in integrating these advanced materials into their products, helping to improve color gamut and energy efficiency. Founded in 2020, QustomDot is focused on innovation in the field of advanced materials.

MRM Health NV is a biopharmaceutical company based in Ghent, Belgium, that specializes in developing microbiome-based therapeutics for metabolic diseases. Founded in early 2020 as a subsidiary of MRM Technologies, the company collaborates with the Flemish Institute of Biotechnology (VIB) to translate scientific research into practical applications. MRM Health is focused on innovative drug development, particularly its lead candidate MH002, aimed at treating Inflammatory Bowel Disease (IBD), which encompasses conditions such as Ulcerative Colitis and Crohn's disease. Through its research and development efforts, MRM Health seeks to advance therapeutic options based on the human microbiome.

Calltic, founded in 2017 and located in Gent, Belgium, specializes in fraud detection services for the telecommunications industry. The company offers an innovative approach to combating telecom fraud, focusing on the rapid and accurate detection of SIM boxes through advanced pattern recognition methods. By utilizing a single tool, Calltic effectively identifies both on-net and off-net fraud, enabling its clients to significantly reduce the financial losses associated with fraudulent activities. This comprehensive solution aims to outperform traditional call detail record profiling techniques, providing a more efficient way for telecom operators to protect their revenues.

Biotalys NV is an agricultural technology company based in Ghent, Belgium, that specializes in the research and development of biopesticides aimed at controlling pests and diseases affecting crops and harvested products. The company utilizes its proprietary Agrobody technology platform to create protein-based crop protection solutions that effectively bind to leaves, seeds, and fruits, enabling targeted delivery of active ingredients. This innovative approach combines the performance of traditional chemical pesticides with the safety profile of biological alternatives, making Biotalys' products suitable for both pre- and post-harvest applications. Founded in 2013, Biotalys is committed to providing sustainable and safe food protection solutions, positioning itself as a leader in the evolution of agricultural practices.

Unifly is a drone traffic management software company focused on the safe integration of drones into the global airspace. Founded in 2015 by aerospace experts, the company emerged from a vision shared by air traffic controllers and engineers to manage the increasing presence of unmanned aircraft. Unifly's award-winning platform allows drone operators to check the legal status of their flights while enabling authorities to monitor and manage drone traffic effectively. The platform is currently utilized by national authorities in countries such as Germany, Denmark, Austria, and Belgium, and is also active in the United States and Africa. Unifly has established itself as a leader in unmanned traffic management technology, working collaboratively with various stakeholders, including research entities and businesses, to enhance airspace safety and efficiency. By providing essential tools for drone operators and regulators, Unifly aims to facilitate the seamless integration of drones into daily life while prioritizing safety and transparency.

SmartNodes S.A., founded in 2014 and based in Liege, Belgium, specializes in innovative lighting systems and solutions aimed at enhancing urban environments. The company's flagship product, the smart lighting system (SLS-G3), integrates various components including node units and power units, alongside systems for smart lighting control and noise monitoring. SmartNodes focuses on providing energy-efficient solutions that lower power consumption while ensuring safety and visual comfort for users. By adjusting light levels based on the presence of pedestrians and vehicles, the company effectively reduces light pollution and the ecological footprint of public lighting systems. Its offerings cater to both public authorities and the private sector, aiming to transform urban lighting through advanced technology and sustainability. As of July 2019, SmartNodes operates as a subsidiary of Lacroix SA.

Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company focuses on developing internal drug discovery programs centered on G-protein coupled receptors (GPCRs), which are critical targets for therapeutic intervention. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes active-state conformations of GPCRs, enabling researchers to access previously unreachable structural features. This innovation facilitates the discovery of novel agonists, addressing unmet medical needs and potentially leading to improved treatments in the medical field. The company aims to build a robust portfolio of drug discovery programs, leveraging its unique approach to enhance therapeutic options.

Track4C, founded in 2012, specializes in providing end-to-end container and cargo tracking services aimed at enhancing supply chain transparency. The company delivers affordable and effective solutions by offering both hardware and software tools necessary for tracking containers or fleets. Utilizing GSM technology, Track4C enables clients to access real-time information through a web-based dashboard, facilitating seamless integration with existing ICT systems. This approach significantly reduces administrative burdens and operational costs for businesses. The company benefits from support by various business incubators and has received substantial funding from prominent venture capital firms in Belgium. Its management team possesses extensive experience in telecommunications and other diverse fields, positioning Track4C as a key player in the logistics and supply chain sector.